Raising the Bar: The Curative Potential of Human Cancer Immunotherapy
Author:
Affiliation:
1. Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract
Publisher
American Association for the Advancement of Science (AAAS)
Subject
General Medicine
Reference41 articles.
1. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2. Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
3. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
4. Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007
5. Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
Cited by 215 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer;Journal of Hematology & Oncology;2024-07-27
2. The reactive stroma response regulates the immune landscape in prostate cancer;Journal of Translational Genetics and Genomics;2024-07-24
3. Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study;JCO Oncology Practice;2024-07-22
4. Small-molecule modulators of tumor immune microenvironment;Bioorganic Chemistry;2024-04
5. Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review;Medical Oncology;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3